Serge K. Lyashchenko

机构：Memorial Sloan Kettering Cancer Center

发表论文 170 篇 · 总被引 4904 次 · h-index 38

代表论文

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics (2024 · The Lancet Oncology · 被引 66)
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial (2024 · The Lancet Oncology · 被引 56)
First-in-Human Evaluation of Site-Specifically Labeled 89 Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer (2024 · Journal of Nuclear Medicine · 被引 49)
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework (2024 · EJNMMI Radiopharmacy and Chemistry · 被引 36)
Good practices for 89Zr radiopharmaceutical production and quality control (2024 · EJNMMI Radiopharmacy and Chemistry · 被引 32)
First in‐human evaluation of [ 1‐ 13 C ]pyruvate in D 2 O for hyperpolarized MRI of the brain: A safety and feasibility study (2024 · Magnetic Resonance in Medicine · 被引 20)